Calcium antagonism with felodipine in essential hypertension. Effects on cardiovascular and renal function, the sympathetic and the renin-angiotensin-aldosterone systems, glucose tolerance and glucoregulatory hormones.
Katzman
P L
PL
Department of Endocrinology, University of Lund, Malmö General Hospital, Sweden.
D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D005080:Exercise Test; D015736:Felodipine; D005934:Glucagon / Q000097:blood; D006339:Heart Rate; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007328:Insulin / Q000097:blood; D007668:Kidney / Q000503:physiopathology; D008875:Middle Aged; D009568:Nitrendipine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012084:Renin-Angiotensin System; D013564:Sympathetic Nervous System / Q000502:physiology
D001786:Blood Glucose; D002121:Calcium Channel Blockers; D007328:Insulin; D005934:Glucagon; D009568:Nitrendipine; D015736:Felodipine